XML 14 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Assets    
Investments, at fair value: $ 1,788,462 [1] $ 1,760,030
Cash 11,515 82,739
Interest receivable on investments 33,200 26,526
Receivable due on investments sold and repaid 997 1,016
Dividends receivable on controlled investments 0 1,275
Prepaid expenses and other assets 608 825
Total assets 1,834,782 1,872,411
Liabilities    
Financing arrangements (net of unamortized debt issuance costs of $8,976 and $6,178, respectively) 976,737 951,322
Accounts payable and accrued expenses 1,344 1,012
Interest payable 8,183 7,820
Accrued management fees 6,546 6,924
Accrued subordinated incentive fee on income 4,967 5,065
Accrued administrative services expense 574 1,703
Shareholder distribution payable 67 14,931
Total liabilities 998,418 988,777
Commitments and contingencies (Note 4 and Note 11)
Shareholders' Equity    
Common stock, $0.001 par value; 500,000,000 shares authorized; 54,961,455 and 55,299,484 shares issued and 54,961,455 and 55,299,484 shares outstanding, respectively 55 55
Capital in excess of par value 1,037,729 1,044,547
Accumulated distributable losses (201,420) (160,968)
Total shareholders' equity 836,364 883,634
Total liabilities and shareholders' equity $ 1,834,782 $ 1,872,411
Net asset value per share of common stock at end of period $ 15.31 $ 15.98
Non-controlled, non-affiliated investments    
Assets    
Investments, at fair value: $ 1,510,372 $ 1,525,040
Non-controlled, affiliated investments    
Assets    
Investments, at fair value: 198,084 143,876
Controlled investments    
Assets    
Investments, at fair value: $ 80,006 $ 91,114
[1] Fair value determined in good faith by the Company’s board of directors (see Note 9), including via delegation to CIM as the Company’s valuation designee (see Note 2), using significant unobservable inputs unless otherwise noted.